Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Feb 8;12(4):1345.
doi: 10.3390/jcm12041345.

A Stepwise Screening Protocol for Multiple Myeloma

Affiliations

A Stepwise Screening Protocol for Multiple Myeloma

Marta Morawska et al. J Clin Med. .

Abstract

Background: Monoclonal gammopathies and multiple myeloma should be screened in the primary care setting.

Methods: The screening strategy consisted of an initial interview supported with the analysis of basic laboratory test results and the increasing laboratory workload in the following steps was developed based on characteristics of patients with multiple myeloma.

Results: The developed 3-step screening protocol includes evaluation of myeloma-related bone disease, two renal function markers, and three hematologic markers. In the second step, the erythrocyte sedimentation rate (ESR) and the level of C-reactive protein (CRP) were cross-tabulated to identify persons qualifying for confirmation of the presence of monoclonal component. Patients with diagnosed monoclonal gammopathy should be referred to a specialized center to confirm the diagnosis. The screening protocol testing identified 900 patients with increased ESR and normal level of CRP and 94 of them (10.4%) had positive immunofixation.

Conclusions: The proposed screening strategy resulted in an efficient diagnosis of monoclonal gammopathy. The stepwise approach rationalized the diagnostic workload and cost of screening. The protocol would support primary care physicians, standardizing the knowledge about the clinical manifestation of multiple myeloma and the method of evaluation of symptoms and diagnostic test results.

Keywords: monoclonal gammopathy; multiple myeloma; screening.

PubMed Disclaimer

Conflict of interest statement

The authors have no conflict of interest to declare.

References

    1. Friese C.R., Abel G.A., Magazu L.S., Neville B.A., Richardson L.C., Earle C.C. Diagnostic delay and complications for older adults with multiple myeloma. Leuk. Lymphoma. 2009;50:392–400. doi: 10.1080/10428190902741471. - DOI - PMC - PubMed
    1. Kariyawasan C.C., Hughes D.A., Jayatillake M.M., Mehta A.B. Multiple myeloma: Causes and consequences of delay in diagnosis. QJM. 2007;100:635–640. doi: 10.1093/qjmed/hcm077. - DOI - PubMed
    1. Howell D., Smith A., Appleton S., Bagguley T., Macleod U., Cook G., Patmore R., Roman E. Multiple myeloma: Routes to diagnosis, clinical characteristics and survival-findings from a UK population-based study. Br. J. Haematol. 2017;177:67–71. doi: 10.1111/bjh.14513. - DOI - PMC - PubMed
    1. Lyratzopoulos G., Saunders C.L., Abel G.A., McPhail S., Neal R.D., Wardle J., Rubin G.P. The relative length of the patient and the primary care interval in patients with 28 common and rarer cancers. Br. J. Cancer. 2015;112((Suppl S1)):S35–S40. doi: 10.1038/bjc.2015.40. - DOI - PMC - PubMed
    1. Lyratzopoulos G., Neal R.D., Barbiere J.M., Rubin G.P., Abel G.A. Variation in number of general practitioner consultations before hospital referral for cancer: Findings from the 2010 National Cancer Patient Experience Survey in England. Lancet Oncol. 2012;13:353–365. doi: 10.1016/S1470-2045(12)70041-4. - DOI - PubMed